Contact Jacoby & Meyers
Dangerous Drug Lawyers
Call us Today 800-977-5614

Minocin is an antibiotic that fights bacteria in the body. It has been used to treat urinary tract infections, respiratory infections, skin infections, acne, gonorrhea, tick fever, chlamydia and other conditions. This drug works by slowing the growth of bacteria in the body. Minocin was approved by the FDA in 1972 and is classified as a tetracycline. The drug is sold under a variety of names.
Minocin has been linked to serious side effects such as loss of vision or total blindness. The drug has been associated to a condition called papilledema, which is swelling of the optic disc. Although discontinuation of this drug has been seen to reverse these effects, often the optic nerves have suffered from permanent damage. This damage has been known to cause permanent blindness in patients.
In 1999, Minocin was also linked to serious side effects in young patients taking the drug for acne. According to the Archives of Internal Medicine, 27,688 patients from ages 15-29 were studied while taking the antibiotic. It was found in the study that these patients were 8.5 times more likely to develop lupus-like syndrome after taking Minocin.
Serious side effects may include:
Less serious side effects may include:
Lawyer Advertising. This website is designed for general information only, and in no way is intended to constitute legal advice nor the formation of a lawyer/client relationship without a signed, written agreement. Testimonials or endorsements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. You pay no fees or costs unless we recover for you. This website contains dramatizations. Prior results are not a guarantee of a future outcome. Jacoby & Meyers does not accept all cases and works cooperatively with co-counsel and/or other law firms with whom it has joint agreements who might potentially handle your cases. We look forward to helping you with your claim.
© 2012-2025 Jacoby & Meyers. All rights reserved.